Trial intelligence / Profile preview

Randomised trial of rectal stimulants for neurogenic bowel after spinal cord injury

2006-006855-10Phase 4Unknown

Sponsor
Buckinghamshire Healthcare NHS Trust
Start
Jan 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of Lecicarbon, glycerol, bisacodyl, docusate sodium and Micralax in neurogenic bowel (NBD) (5 arms), sponsored by Buckinghamshire Healthcare NHS Trust. Primary endpoint: Total duration of bowel management. Status: unknown.

02

Drugs

Lecicarbonglycerolbisacodyldocusate sodiumMicralax
03

Conditions

neurogenic bowel (NBD)

Beyond the preview

Go deeper on 2006-006855-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006855-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call